Publications
The ATTACC, ACTIV-4a, and REMAP-CAP Investigators (2021). Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. The New England Journal of Medicine; DOI: 10.1056/NEJMoa2105911
The ATTACC, ACTIV-4a, and REMAP-CAP Investigators (2021). Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. The New England Journal of Medicine; DOI: 10.1056/NEJMoa2105911